SunEdison Flies Sky-High on Acquisition Deal


Sunedison Inc (NYSE:SUNE), Allied Nevada Gold Corp. (NYSEMKT:ANV) and InvenSense Inc (NYSE:INVN) hit midday in the green this Tuesday. Globalstar, Inc. (NYSEMKT:GSAT), Cal Dive International, Inc. (OTCMKTS:CDVI) and Amicus Therapeutics, Inc. (NASDAQ:FOLD), on the other hand, are in the red.

Sign Up For Our Free Newsletter


Jim Chanos Unveils Lastest Short As Fund Manager Bets On Further Market Declines

Data 1639507577Jim Chanos has a new short target in his sights. Earlier this week, the hedge fund manager disclosed that he is betting against "legacy" data centers that face growing competition from the trio of technology giants, which have previously been their biggest customers. The fund manager, who is best known for his winning bet against Read More

SunEdison Surges

Sunedison Inc (NYSE:SUNE) surged +25.05% early in the day on the heels of news that it will acquire First Wind in a $2.4 billion deal. The solar energy company, a billionaire favorite, is in the portfolios of hedge fund magnates David Einhorn, Leon Cooperman and Dan Loeb, among others. It’s climbed +60.84% this year.


Allied Nevada Gold Corp. (NYSEMKT:ANV) got a +10.78% boost today thanks to gold price increases. John Paulson has maintained a position in the gold and silver producer across several quarters, and George Soros initiated a position in the company in Q2.

Up +8.05% midday, InvenSense Inc (NYSE:INVN) has bounced a bit today, though it’s still down-25.89% for the year. The company, which is rumored to be a potential Qualcomm acquisition candidate, has been in Soros’ portfolio since the start of 2014.

Globalstar Tumbles Following CEO’s CNBC Stop

Globalstar, Inc. (NYSEMKT:GSAT) tumbled -8.57% today, just 24 hours after company CEO Jay Monroe paid a visit to CNBC to defend the stock. The George Soros pick has climbed +48% YTD.

Cal Dive International, Inc. (OTCMKTS:CDVI) dipped -5.69%, bringing its five-day loss to -35.56%. The marine contracting company has had a brutal 2014, its price falling -97.11% since the start of the year.

The share price of Amicus Therapeutics, Inc. (NASDAQ:FOLD) fell -5.67% today, coming back down a bit after yesterday’s surge. The stock has surged an impressive +171.06% YTD.


Updated on

Sheeraz is our COO (Chief - Operations), his primary duty is curating and editing of ValueWalk. He is main reason behind the rapid growth of the business. Sheeraz previously ran a taxation firm. He is an expert in technology, he has over 5.5 years of design, development and roll-out experience for SEO and SEM. - Email: sraza(at)
Previous article Morgan Creek Opportunity Fund Looks To Japan For Opportunity
Next article Does Ethnic Diversity Deflate Asset Bubbles?

No posts to display